| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/06/2002 | CA2439472A1 Methods and compositions for modifying apolipoprotein b mrna editing |
| 09/06/2002 | CA2439465A1 Prophylactic teat treatment |
| 09/06/2002 | CA2439376A1 Compositions and methods of manufacture for oral dissolvable dosage forms |
| 09/06/2002 | CA2439366A1 Pharmaceutical formulation comprising bicalutamide |
| 09/06/2002 | CA2439100A1 Eye drop |
| 09/06/2002 | CA2438956A1 A vaccine composition and method of using the same |
| 09/06/2002 | CA2438907A1 Manufacture of thyroid hormone tablets having consistent active moiety amounts |
| 09/06/2002 | CA2438784A1 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 09/06/2002 | CA2438696A1 Polynucleotide formulation for enhanced intracellular transfer |
| 09/06/2002 | CA2438652A1 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 09/06/2002 | CA2438630A1 Composition for freshening nostrils and sinus cavities |
| 09/06/2002 | CA2438273A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 09/06/2002 | CA2438268A1 Modulation of release from dry powder formulations |
| 09/06/2002 | CA2438193A1 Novel dendritic polymers and their biomedical uses |
| 09/06/2002 | CA2438174A1 Labeled macrophage scavenger receptor antagonists for imaging atherosclerosis and vulnerable plaque |
| 09/06/2002 | CA2435815A1 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer |
| 09/06/2002 | CA2435291A1 Functionalized cubic liquid crystalline phase materials and methods for their preparation and use |
| 09/06/2002 | CA2410802A1 A stable pharmaceutical formulation comprising torsemide modification ii |
| 09/05/2002 | US20020123741 Platen pump |
| 09/05/2002 | US20020123740 Transcutaneous delivery means |
| 09/05/2002 | US20020123678 Device for enhanced delivery of biologically active substances and compounds in an organism |
| 09/05/2002 | US20020123521 Such as triiodothyroacetic acid, triiodopropionic acid, 4-(2,6-dibromo-4-(1H-tetrazol-5-ylmethyl)-phenoxy)-2-isopropyl-phenol, and 4-(4-hydroxymethyl-2,6-diiodophenoxy)-2-iodo-phenol |
| 09/05/2002 | US20020123512 Pharmaceutical composition |
| 09/05/2002 | US20020123511 Paroxetine adsorbed or absorbed on a solid carrier to form a free-flowing powder useful for capsule filling or for tablet formation; treating depression |
| 09/05/2002 | US20020123504 In an inert carrier; instant release; treating allergic rhinitis and other histamine-induced disorders |
| 09/05/2002 | US20020123503 Excipient and cabergoline prepared by wet granulation process using a nonaqueous granulating fluid to preserve the stability of cabergoline and permit homogenous dispersion |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
| 09/05/2002 | US20020123482 Artificial tear composition containing a combination of three demulcents |
| 09/05/2002 | US20020123478 Synthetic transfection vectors |
| 09/05/2002 | US20020123476 For treating infectious diseases and genetic disorders through gene therapy and intracellular delivery of antisense oligonucleotides or other nucleic acid sequences |
| 09/05/2002 | US20020123459 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 09/05/2002 | US20020123142 Generating cell culture; obtain cells, deposit on dextran beadlets, culture, separate cells from beadlets by digestion with dextranase |
| 09/05/2002 | US20020122843 Coating includes a metal salt,especially a copper or zinc salt |
| 09/05/2002 | US20020122833 Herbal compositions for treating immunological disorders |
| 09/05/2002 | US20020122828 A porous inorganic material having a polymer network integrated within the pores of the porous inorganic material; preferred polymer precursors include poly(N-isopropylacrylamide) |
| 09/05/2002 | US20020122827 Atomizing liquid solutions of the macromolecules, drying the droplets, and collecting the particles; process control; especially for proteins, a nucleic acids, and a high molecular weight polysaccharides. |
| 09/05/2002 | US20020122826 Solid peptide preparations for inhalation and their preparation |
| 09/05/2002 | US20020122824 Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids |
| 09/05/2002 | US20020122823 Soft tablet containing dextrose monohydrate |
| 09/05/2002 | US20020122822 Having a friability of less than about 2% from an active ingredient, an excipient in the form of a hydrate, and a water- swellable excipient; and applying energy to decrease the hardness of the tablet by at least 20%. |
| 09/05/2002 | US20020122820 Liposome having at least one recombinant soluble MHC-peptide complex incorporated therein; may also include at least one additional signal molecule for manipulating the intensity and quality of the immune response. |
| 09/05/2002 | US20020122819 Preparing invaginated liposomes by heating 1,2-bis(oleoyloxy) -3-(trimethylammonio)- propane and cholesterol or a derivative; sonicating; and extruding lipid components sequentially through filters of decreasing pore size |
| 09/05/2002 | US20020122817 Solid instant-release forms of administration and process for producing the same |
| 09/05/2002 | US20020122811 Hair wax products containing waxes, non-volatile oils and volatile hydrophobic materials |
| 09/05/2002 | US20020122786 Phosphate-binding polymer preparation technical field |
| 09/05/2002 | US20020122774 Method for dispensing S-Adenosyl-methionine in a micro fine powdered form by inhalation |
| 09/05/2002 | US20020122773 Each optionally in the form of the enantiomers, mixtures of the enantiomers or in the form of the racemates; optionally hydrates or solvates |
| 09/05/2002 | US20020121225 High levels of low viscosity propylene glycol alginate and a surfactant; does not retard the release of active ingredients from the coated substrate. |
| 09/05/2002 | DE10109898A1 Lipide mit veränderlicher Ladung Lipids with variable charge |
| 09/05/2002 | DE10109763A1 Pharmazeutische Salze Pharmaceutical Salts |
| 09/05/2002 | DE10109708A1 Improving solubility and incorporation of phytosterol in foods, nutritional supplements or body care agents by using a concentrate containing an emulsifier such as a polysorbate |
| 09/05/2002 | DE10107828A1 Use of buprenorphin for treating urinary incontinence and related conditions, at below analgesic levels, particularly delivered from skin patches |
| 09/05/2002 | DE10107663A1 Testosteronhaltiges transdermales therapeutisches System und Verfahren zu seiner Herstellung Testosterone-containing transdermal therapeutic system and process for its preparation |
| 09/05/2002 | DE10107659A1 Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin Mucoadhesive disintegratable pharmaceutical preparation for drug delivery in veterinary and human medicine |
| 09/05/2002 | DE10106852A1 Entzündungshemmende Verbindungen Anti-inflammatory compounds |
| 09/04/2002 | EP1236473A2 Self-assembling polynucleotide delivery system |
| 09/04/2002 | EP1236472A1 Glycyrrhizin preparations for transmucosal absorption |
| 09/04/2002 | EP1236467A1 Inhalatory compositions of formoterol |
| 09/04/2002 | EP1236466A1 Absorbable solid compositions for topical treatment of oral mucosal disorders |
| 09/04/2002 | EP1236464A2 Cosmetic, dermatological or pharmaceutical composition without surfactants |
| 09/04/2002 | EP1236462A1 Multi-lamella based emulsion for stabilizing dermatologically useful ingredients and external preparation containing the same |
| 09/04/2002 | EP1235924A1 Antisense modulation of rank expression |
| 09/04/2002 | EP1235922A2 Excipient system that contains coating substances with enzymatically removable side-groups |
| 09/04/2002 | EP1235848A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
| 09/04/2002 | EP1235835A1 Chromium-histidine complexes as nutrient supplements |
| 09/04/2002 | EP1235834A1 (1r,cis)-4-(4-amino-7h-pyrr0l0[2,3- i(d)]pyrimidine-7-yl)-2-cyclopentene-1-methanol derivatives as antiviral |
| 09/04/2002 | EP1235801A2 Solid pharmaceutical preparation |
| 09/04/2002 | EP1235639A1 Compositions including ether-capped poly(oxyalkylated) alcohol wetting agents |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | EP1235598A2 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 09/04/2002 | EP1235597A2 Nucleic acid delivery system |
| 09/04/2002 | EP1235581A2 Use of ribose to prevent cramping and soreness in muscles |
| 09/04/2002 | EP1235580A2 Transdermal system containing acetylsalicylic acid for treatment of migraine |
| 09/04/2002 | EP1235579A1 Pharmaceutical compositions comprising trimegestone |
| 09/04/2002 | EP1235574A2 Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| 09/04/2002 | EP1235571A1 Use of melatonin for treating androgenetic and diffuse alopecia |
| 09/04/2002 | EP1235566A2 Valnemulin formulation |
| 09/04/2002 | EP1235562A1 Chronotherapeutic diltiazem formulations and the administration thereof |
| 09/04/2002 | EP1235561A2 Fast dissolving composition with prolonged sweet taste |
| 09/04/2002 | EP1235560A2 Microchip devices for delivery of molecules and methods of fabrication thereof |
| 09/04/2002 | EP1235559A2 Solid oral dosage form |
| 09/04/2002 | EP1235558A2 Compressed tablet composition comprising a nsaid |
| 09/04/2002 | EP1235557A2 Gastroretentive controlled release pharmaceutical dosage forms |
| 09/04/2002 | EP1235556A2 Taste masking coating compositions |
| 09/04/2002 | EP1235555A2 Stable galenic preparations comprising a benzimidazol and method for the production thereof |
| 09/04/2002 | EP1235487A1 Nutritional composition |
| 09/04/2002 | EP1175390A4 Disodium salts, monohydrates, and ethanol solvates |
| 09/04/2002 | EP1169314B1 Crystalline base of citalopram |
| 09/04/2002 | EP1162951A4 Controlled release bupropion formulation |
| 09/04/2002 | EP1149066A4 Method of preparing alkylated salicylamides |
| 09/04/2002 | EP1041975B1 Rate controlling membranes for controlled drug delivery devices |
| 09/04/2002 | EP1041972B1 Tablet for instant and prolonged release of one or more active substances |
| 09/04/2002 | EP1019105B1 Polar, lipophilic pressure-sensitive adhesive compositions and medical devices using same |
| 09/04/2002 | EP0977583B1 Compositions comprising conjugates of stable, active, human ob protein with immunoglobulin fc chain and methods |
| 09/04/2002 | EP0971690B1 Antiinfective free intramammary veterinary composition |
| 09/04/2002 | EP0949923B1 Stabilised pharmaceutical compositions, based on quinupristine and dalfopristine, and their preparation |
| 09/04/2002 | EP0932389B1 Ophthalmic compositions containing a carbonic anhydrase inhibitor and xanthan gum |
| 09/04/2002 | EP0904063B1 Process for the preparation of microparticles |
| 09/04/2002 | EP0883602B1 Lipids |
| 09/04/2002 | EP0835098B1 New, stable medicinal compositions for generating propellant-free aerosols |